The Global Microfluidic Chips Market size is expected to reach USD 81.13 Billion in 2030 and register a revenue CAGR of 16.2% over the forecast period, according to the latest report by Reports and Data. Increasing importance of Point-Of-Care (POC) testing in medical emergencies for quick diagnosis and decision making is expected to drive market revenue growth during the forecast period. POC devices are widely accepted diagnostic tools in the healthcare sector owing to advantages such as rapid and accurate detection, ease of operation, cost-effectiveness, portability, and non-requirement of specialized professionals.
Microfluidic Chips platforms handle low volume samples such as femtoliters (fL), which is one quadrillionth of a liter. This allows researchers to work with fewer samples and reagents with more accuracy and provide results faster than with traditional methods. The need for immovable desktop scanners or cameras that are sensitive to ambient light conditions makes it difficult to use paper-based colorimetric immunoassays such as enzyme-linked immunosorbent assay (ELISA). Microfluidic POC testing has proven to be a robust and optimal medical technology compared to standard laboratory-based testing, especially in demanding and resource-constrained environments. The COVID-19 pandemic has been one of the major factors driving adoption of POC testing owing to cost-effectiveness and short duration of patient stay in hospital.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3871
The pharma and healthcare industry is expected to observe significant growth over the coming years attributed to the increasing incidence of chronic diseases across the globe, growing geriatric patient pool, availability of advanced and minimally invasive surgical and diagnostics procedures, favorable reimbursement scenario, and presence of a robust product pipeline of drugs and therapeutics. In addition, the growing integration of IoT, ML, and AI in medical procedures and equipment along with rapid progress in drug design and development. A combination of innovation and technology has brought about massive changes in the healthcare industry and the rapid adoption of telemedicine, remote consultation, and e-prescription has significantly contributed to the revenue growth of the market.
Research Methodology:
Reports and Data utilizes a unique approach to research to offer a comprehensive overview of the global Microfluidic Chips Market to offer insights into investment opportunities for stakeholders, investors, clients, and businesses to make informed decisions. The report includes SWOT analysis, Porter’s Five Forces analysis, feasibility analysis, and investment return analysis to offer a better understanding of the market scenario.
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/3871
Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in the healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register the highest market growth over the forecast period attributed to the increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.
The growing popularity of over-the-counter medications driving market growth
Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.
Restriction on product launches and RD activities to hamper the market growth
The imposition of strict government regulations and shortage of funds has put a halt on product launches and RD activities and is expected to restrain market growth over the forecast period. In addition, the launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering the market growth.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as RD investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.
Top Companies Profiled in the Report:
uFluidix, Nanōmix, Inc., Quidel Corporation, biosurfit SA, Abbott, Illumina, Inc., Abaxis, NanoEntek, PerkinElmer Inc., and Bio-Rad Laboratories, Inc.
Microfluidic Chips Market Segmentation:
Components Outlook (Revenue, USD Billion; 2019-2030)
- Microfluidic Chips
- Micropumps
- Microneedles
- Other Components
Application Outlook (Revenue, USD Billion; 2019-2030)
- Drug Delivery
- Point-of-Care (POC) Diagnostics
- Pharmaceutical and Biotechnology Research
- Clinical Diagnostics
- Others
Material Outlook (Revenue, USD Billion; 2019-2030)
- Polymer
- Silicone
- Glass
- Other Materials
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East Africa)
Frequently asked questions addressed in the report:
- What is the revenue growth rate of the global Microfluidic Chips market over the forecast period?
- What are the major factors driving the growth of the Global Microfluidic Chips Market?
- What are the key challenges impacting the global Microfluidic Chips market growth?
- What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?
Request customization on the report @ https://www.reportsanddata.com/request-customization-form/3871
Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.
Explore Latest Trending Research Reports By Reports and Data:
Ptosis Market @ https://www.biospace.com/article/ptosis-market-revenue-trends-company-profiles-revenue-share-analysis-2022-2030/
Bronchitis Treatment Market @ https://www.biospace.com/article/bronchitis-treatment-market-analysis-revenue-share-company-profiles-launches-and-forecast-till-2030/
Herpes Simplex Treatment Market https://www.biospace.com/article/herpes-simplex-treatment-market-market-size-and-analysis-trends-recent-developments-and-forecast-till-2030/
Pecoma Market @ https://www.biospace.com/article/pecoma-market-to-witness-an-outstanding-growth-during-2022-2030/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
